Company / Tangible Book Value per Share
Organon & Co. Tangible Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$13.19
FY2025
5-year range
-$21.67 / $9.59
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#206 of 209
Health Care
What the data says
Among 209 Health Care companies, Organon & Co. is in the bottom 1% for tangible book value per share. Tangible Book Value per Share has increased for 3 consecutive years, from $-21.67 in FY2022 to $-13.19 in FY2025.
Based on SEC 10-K filings.
-13.19 in FY2025.
Improved from $-18.37 to $-13.19 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 209This company -$13.19 Sector average $119.74
▼
-111.0% below sector average
Key checks
Key Insights
- Organon & Co.'s tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 19.9% year-over-year.
- Ranks #206 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.19 | +19.9% |
| FY2024 | -$16.46 | +10.4% |
| FY2023 | -$18.37 | +15.2% |
| FY2022 | -$21.67 | -325.9% |
| FY2021 | $9.59 | +175.4% |
| FY2020 | $3.48 | -87.4% |
| FY2019 | $27.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026